SCHEMBL25823344

SCHEMBL25823344

C1=NNCC1c1ccc2nc(Nc3ccc(N4CCN(C5COC5)CC4)cc3)c3nccn3c2c1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.51
CD63 P08962 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25822728 0.83 SYK (0.55) SYKCD63
SCHEMBL25822684 0.79 SYK (0.57) SYKCD63
SCHEMBL25823831 0.75 SYK (0.49) SYKCD63
SCHEMBL16848683 0.72 SYK (0.68) SYKCD63
SCHEMBL25822732 0.72 SYK (0.48) SYKCD63
SCHEMBL25822712 0.71 MAPT (0.58) SYKCD63
SCHEMBL16851493 0.68 SYK (0.71) SYKCD63
SCHEMBL15551918 0.68 SYK (0.69) SYKCD63
SCHEMBL28564010 0.68 SYK (0.69) SYKCD63
SCHEMBL25822735 0.68 MAPKAPK5 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 SYK, KDR, FLT1 SYK 1/4885CD63 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.